Researchers from Aarhus University have made a significant breakthrough by discovering that the drug 4-OI can enhance the effectiveness of a cancer-fighting viral agent. This may lead to treatment of cancers that are otherwise resistant to therapies.
"We found that if we administer a specific viral agent called Vesicular Stomatitis Virus along with a metabolite-drug called 4-Octyl-Itaconate , we are able to treat cancers that are considered resistant to viral infections." "It is the combination of the specific virus and the drug that brings about a completely unique proviral effect, which potentially can have a significant impact on patients affected by cancer that we are currently unable to treat," explains David Olagnier.
For the research team, the next step is a more extensive pre-clinical testing of the combinational use of VSVD51 and 4-OI.
Source: Healthcare Press (healthcarepress.net)
Cancer HIV And AIDS Lung Cancer Weapons Technology Thermodynamics Engineering
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: FoxNews - 🏆 9. / 87 Read more »
Source: SciTechDaily1 - 🏆 84. / 68 Read more »
Source: SciTechDaily1 - 🏆 84. / 68 Read more »
Source: IntEngineering - 🏆 287. / 63 Read more »
Source: SciTechDaily1 - 🏆 84. / 68 Read more »
Source: FOX10Phoenix - 🏆 83. / 68 Read more »